Experimental Duchenne Muscular Dystrophy Treatment Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Duchenne Muscular Dystrophy Treatment Earns Rare Pediatric Disease Designation

According to a story from apnews.com, the biopharmaceutical company FibroGen, Inc., has recently announced that its investigational treatment pamrevlumab has earned Rare Pediatric Disease designation from the US Food and…

Continue Reading Experimental Duchenne Muscular Dystrophy Treatment Earns Rare Pediatric Disease Designation
Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
source: pixabay.com

Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19

In a case study published on dovepress.com, a 17 year old girl diagnosed with COVID-19 developed Guillain-Barre syndrome, a neurological disease causing muscle weakness, as her symptoms progressed. While COVID-19…

Continue Reading Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
Long COVID/Myalgic Encephalomyelitis Continues to Receive Criticism from Psychiatrists
source: pixabay.com

Long COVID/Myalgic Encephalomyelitis Continues to Receive Criticism from Psychiatrists

According to a story from insidesources.com, many in the chronic fatigue syndrome/myalgic encephalomyelitis community has been very grateful for the news that the National Institutes of Health (NIH) has committed…

Continue Reading Long COVID/Myalgic Encephalomyelitis Continues to Receive Criticism from Psychiatrists
Rare Classroom: Hyponatremia
source: shutterstock

Rare Classroom: Hyponatremia

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Hyponatremia
“Long COVID” Has Brought New Attention to Myalgic Encephalomyelitis
source: pixabay.com

“Long COVID” Has Brought New Attention to Myalgic Encephalomyelitis

According to a story from PR Newswire, Solve M.E. is gathering virtually on Capitol Hill for its 5th Annual Advocacy Week, starting April 19th. A record number of people are…

Continue Reading “Long COVID” Has Brought New Attention to Myalgic Encephalomyelitis